TXG 10x Genomics, Inc.
Company Analysis
Latest News
🔴 10x Genomics falls 5.2% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🔴 10x Genomics is trading 5% down as hotter U.S. inflation fuels rate concerns
10x Genomics is trading at $70.33, with a -4.80% change, amid broader technology weakness. - No clear company-specific announcement explains the October 15...
🔴 10x Genomics is trading 5% down in pre-market amid rate concerns weighing on technology shares
10x Genomics is trading 4.91% lower at $69.51 in pre-market on October 15, with no clear company-specific announcement explaining the decline; broader...
🔴 10x Genomics is trading 4.4% down today amid valuation concerns
10x Genomics is trading 4.4% down at $71.88 on October 13, as coverage cites valuation concerns and profit-taking after a substantial rally. - The stock fell...
🔴 10x Genomics is trading 10% down on October 12, 2026 — with no confirmed company-specific catalyst
10x Genomics is trading at $72.43, down 10.19%, with no confirmed company-specific catalyst identified for the October 12 decline. - Latest surfaced company...
🔴 10x Genomics is trading 4.1% down with no clear catalyst identified
10x Genomics is trading 4.1% lower at $77.35 on October 12, 2026; no confirmed company-specific catalyst has been identified. - Recent coverage has discussed...
🟢 10x Genomics is trading 6% up
10x Genomics is trading at $82.04, up 6.16%, with no confirmed company-specific announcement or direct catalyst for the October 9 move in available...
🔴 10x Genomics is trading 6.7% down amid higher yields and oil prices
10x Genomics is trading at $71.01, down 6.69%, amid broader market pressure consistent with higher oil prices and Treasury yields. - No clear company-specific...
🔴 10x Genomics is trading 5% down in pre-market amid rising yields and oil prices
10x Genomics is trading at $72.53, down 4.69% in pre-market amid broader market pressure; no clear company-specific catalyst was identified. - Shares fell...
🔴 10x Genomics is trading 6.8% down today as major indexes fall amid rising yields
10x Genomics is trading 6.8% down at $73.86 amid broader market pressure, with no fresh company-specific catalyst identified. - The S&P 500, Nasdaq and Dow are...
🔴 10x Genomics is trading 10.2% down today amid biotech weakness, with no new company-specific catalyst identified
10x Genomics is trading at $87.76, down 10.21%, with biotech-sector weakness as relevant context; no fresh company-specific announcement explaining the October...
🔴 10x Genomics is trading 6.5% down today amid biotech-sector weakness
10x Genomics is trading at $91.39, down 6.50%, with no fresh company-specific announcement explaining the decline. - The latest company news found was...
🟢 10x Genomics is trading 4.84% up
10x Genomics is trading 4.84% up at $102.47 as of 9:36 a.m. EST on October 6, 2026, with no specific catalyst identified. - No fresh company announcement for...
🟢 10x Genomics is trading 4.3% up today as technology and growth stocks advance
10x Genomics is trading at $97.52, up 4.30%, amid supportive broader-market sentiment; no clear company-specific catalyst was identified. - At 2:25 p.m. EST...
🟢 10x Genomics is trading 5% up today amid broader market gains
10x Genomics is trading at $93.39, up 5.22%, with no clear company-specific catalyst identified for the move. - No 10x Genomics-specific catalyst dated October...
🟢 10x Genomics is trading 4.37% up today as Atera orders top 2026 shipment expectations
10x Genomics is trading at $93.97, up 4.37%, amid strong orders for its newly launched Atera system. - Commercial Atera shipments began September 29; booked...
10x Genomics Starts Atera Shipments as Orders Top 2026 Expectations
10x Genomics has begun the first commercial shipments of its Atera instrument, a spatial biology platform introduced in April 2026. Booked orders have already...
🟢 10x Genomics is trading 4.03% up, as patent-win momentum continues
10x Genomics is trading at $89.16, up 4.03%, as company-specific momentum extends its recent rally. - Reports linked the September 24 surge to a favorable...
🟢 10x Genomics is trading 10.14% up today with no confirmed catalyst
10x Genomics is trading 10.14% higher at $83.29, with no confirmed company-specific catalyst identified for September 24. - The rebound follows a 6.29%...
🟢 10x Genomics is trading 7.2% up today
10x Genomics is trading at $81.03, up 7.15%, with no confirmed catalyst for the rebound. - No clear company-specific announcement was reported on September...